These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 26414464)

  • 1. Langerhans Cell Histiocytosis: A Clinicopathologic Review and Molecular Pathogenetic Update.
    Harmon CM; Brown N
    Arch Pathol Lab Med; 2015 Oct; 139(10):1211-4. PubMed ID: 26414464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Langerhans cell histiocytosis: a clinicopathologic and immunohistochemical analysis of 258 cases].
    Xu X; Liu WP; Yang QP; Wang WY; Liao DY; Zhao S; Bi CF; Lin L; Min M
    Zhonghua Bing Li Xue Za Zhi; 2012 Feb; 41(2):91-6. PubMed ID: 22455884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Langerhans cell hyperplasia in scabies: a mimic of Langerhans cell histiocytosis.
    Bhattacharjee P; Glusac EJ
    J Cutan Pathol; 2007 Sep; 34(9):716-20. PubMed ID: 17696920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous adult xanthogranuloma with a small portion of BRAF
    Ishikawa M; Endo Y; Uehara A; Suto M; Yasuda M; Motegi SI; Ishikawa O
    J Dermatol; 2019 Feb; 46(2):161-165. PubMed ID: 30536719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Langerhans Cell Histiocytosis Associated With Renal Cell Carcinoma Is a Neoplastic Process: Clinicopathologic and Molecular Study of 7 Cases.
    Agaimy A; Bonert M; Naqvi A; Wang C; Trpkov K; Dettmar P; Wintzer HO; Stoehr R; Hes O; Williamson SR; Gibson IW; Hartmann A
    Am J Surg Pathol; 2020 Dec; 44(12):1658-1665. PubMed ID: 32910018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uncommon cutaneous non-Langerhans cell histiocytosis arising from dermal dendritic cells in adults: a clinicopathological study of five cases.
    Nong L; Ren Y; Dong Y; Li D; Li X; Li T
    Eur J Dermatol; 2020 Feb; 30(1):32-40. PubMed ID: 32250254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis of Langerhans cell histiocytosis.
    Badalian-Very G; Vergilio JA; Fleming M; Rollins BJ
    Annu Rev Pathol; 2013 Jan; 8():1-20. PubMed ID: 22906202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fine Needle Aspiration of Langerhans Cell Histiocytosis: A Cytopathologic Study of 37 Cases.
    Hang JF; Siddiqui MT; Ali SZ
    Acta Cytol; 2017; 61(2):96-102. PubMed ID: 28407623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Langerhans cell histiocytosis in adults: Advances in pathophysiology and treatment.
    Kobayashi M; Tojo A
    Cancer Sci; 2018 Dec; 109(12):3707-3713. PubMed ID: 30281871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Langerhans cell histiocytosis: A neoplastic disorder driven by Ras-ERK pathway mutations.
    Tran G; Huynh TN; Paller AS
    J Am Acad Dermatol; 2018 Mar; 78(3):579-590.e4. PubMed ID: 29107340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress in understanding the pathogenesis of Langerhans cell histiocytosis: back to Histiocytosis X?
    Berres ML; Merad M; Allen CE
    Br J Haematol; 2015 Apr; 169(1):3-13. PubMed ID: 25430560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Langerhans cell histiocytosis in IPEX syndrome: possible role for natural regulatory T cells?
    Sayar E; Uygun DF; Islek A; Hazar-Sayar E; Akkaya B; Vignoli M; Gambineri E; Yesilipek MA; Artan R
    Pediatr Allergy Immunol; 2014 Oct; 25(6):601-3. PubMed ID: 24628744
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunohistochemical analysis of langerin in langerhans cell histiocytosis and pulmonary inflammatory and infectious diseases.
    Sholl LM; Hornick JL; Pinkus JL; Pinkus GS; Padera RF
    Am J Surg Pathol; 2007 Jun; 31(6):947-52. PubMed ID: 17527085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationale for the application of RANKL inhibition in the treatment of Langerhans cell histiocytosis.
    Makras P; Salagianni M; Revelos K; Anastasilakis AD; Schini M; Tsoli M; Kaltsas G; Andreakos E
    J Clin Endocrinol Metab; 2015 Feb; 100(2):E282-6. PubMed ID: 25375981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of the V600D mutation in Exon 15 of the BRAF oncogene in congenital, benign langerhans cell histiocytosis.
    Kansal R; Quintanilla-Martinez L; Datta V; Lopategui J; Garshfield G; Nathwani BN
    Genes Chromosomes Cancer; 2013 Jan; 52(1):99-106. PubMed ID: 22996177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Langerhans' cell histiocytosis].
    Fu LB; He LJ
    Zhonghua Bing Li Xue Za Zhi; 2005 Nov; 34(11):752-3. PubMed ID: 16536327
    [No Abstract]   [Full Text] [Related]  

  • 17. Genomic Alterations in Langerhans Cell Histiocytosis.
    Rollins BJ
    Hematol Oncol Clin North Am; 2015 Oct; 29(5):839-51. PubMed ID: 26461146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between clinicopathologic characteristics and BRAF
    Huang H; Lu T; Sun Y; Li S; Li J; Xu K; Feng RE; Xu ZJ
    Thorac Cancer; 2019 Oct; 10(10):1984-1992. PubMed ID: 31441596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological and clinical significance of somatic mutations in Langerhans cell histiocytosis and related histiocytic neoplastic disorders.
    Allen CE; Parsons DW
    Hematology Am Soc Hematol Educ Program; 2015; 2015():559-64. PubMed ID: 26637772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Langerhans cell histiocytosis mimicking malignant melanoma: a diagnostic pitfall.
    Billings TL; Barr R; Dyson S
    Am J Dermatopathol; 2008 Oct; 30(5):497-9. PubMed ID: 18806499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.